Differentiated thyroid cancer patients who receive radioiodine (RAI) treatment after surgery have increased relative survival rates compared to those who do not receive the treatment. According to new ...

Survival rates for melanoma can help provide a generic baseline for a person’s outlook. However, several factors play a role in determining outcomes, and the condition will affect each person ...

Relative survival analysis quantifies the survival of cancer patients by comparing observed survival in a patient cohort with the expected survival of a comparable segment of the general population.

About 40 percent of patients with lower-risk myelodysplastic syndromes (LR-MDS) die of MDS within five years, according to a study published online Nov. 6 in the British Journal of Haematology.

Although data from 1975 to 1997 revealed a gap in cancer survival improvement in adolescents and young adults (AYAs; 15-39 years) compared with children and older adults, more recent studies have ...

The 5-year relative survival rate for stomach cancer is 37.9%. However, individual survival rates vary depending on factors such as a person’s overall health and the stage of the disease. The above ...

The relative survival rate represents the probability of a patient living for another five years, as compared to a random person of the same age, race, and sex. See ...

Survival rates for gallbladder cancer depend on the stage of cancer at the time of diagnosis. In the United States, the combined 5-year relative survival rate across all stages (local, regional, and ...

Graphical Abstract. Relative survival with and without radioiodine therapy (RAI) in intermediate risk papillary thyroid cancer (PTC) and low risk, minimally invasive follicular thyroid cancer (FTC). A ...